These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27457620)

  • 1. Structure-Activity Analysis of Gram-positive Bacterium-producing Lasso Peptides with Anti-mycobacterial Activity.
    Inokoshi J; Koyama N; Miyake M; Shimizu Y; Tomoda H
    Sci Rep; 2016 Jul; 6():30375. PubMed ID: 27457620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning of the gene cluster for lariatin biosynthesis of Rhodococcus jostii K01-B0171.
    Inokoshi J; Matsuhama M; Miyake M; Ikeda H; Tomoda H
    Appl Microbiol Biotechnol; 2012 Jul; 95(2):451-60. PubMed ID: 22388571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lasso Peptide Biosynthetic Protein LarB1 Binds Both Leader and Core Peptide Regions of the Precursor Protein LarA.
    Cheung WL; Chen MY; Maksimov MO; Link AJ
    ACS Cent Sci; 2016 Oct; 2(10):702-709. PubMed ID: 27800552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lariatins, novel anti-mycobacterial peptides with a lasso structure, produced by Rhodococcus jostii K01-B0171.
    Iwatsuki M; Uchida R; Takakusagi Y; Matsumoto A; Jiang CL; Takahashi Y; Arai M; Kobayashi S; Matsumoto M; Inokoshi J; Tomoda H; Omura S
    J Antibiot (Tokyo); 2007 Jun; 60(6):357-63. PubMed ID: 17617692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lariatins, antimycobacterial peptides produced by Rhodococcus sp. K01-B0171, have a lasso structure.
    Iwatsuki M; Tomoda H; Uchida R; Gouda H; Hirono S; Omura S
    J Am Chem Soc; 2006 Jun; 128(23):7486-91. PubMed ID: 16756302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lys17 in the 'lasso' peptide lariatin A is responsible for anti-mycobacterial activity.
    Iwatsuki M; Koizumi Y; Gouda H; Hirono S; Tomoda H; Omura S
    Bioorg Med Chem Lett; 2009 May; 19(10):2888-90. PubMed ID: 19362475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lassomycin and lariatin lasso peptides as suitable antibiotics for combating mycobacterial infections: current state of biosynthesis and perspectives for production.
    Zhu S; Su Y; Shams S; Feng Y; Tong Y; Zheng G
    Appl Microbiol Biotechnol; 2019 May; 103(10):3931-3940. PubMed ID: 30915503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the biosynthesis and stability of the lasso peptide capistruin.
    Knappe TA; Linne U; Robbel L; Marahiel MA
    Chem Biol; 2009 Dec; 16(12):1290-8. PubMed ID: 20064439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthetic Gene Cluster of a d-Tryptophan-Containing Lasso Peptide, MS-271.
    Feng Z; Ogasawara Y; Nomura S; Dairi T
    Chembiochem; 2018 Oct; 19(19):2045-2048. PubMed ID: 29974638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence determinants governing the topology and biological activity of a lasso peptide, microcin J25.
    Ducasse R; Yan KP; Goulard C; Blond A; Li Y; Lescop E; Guittet E; Rebuffat S; Zirah S
    Chembiochem; 2012 Feb; 13(3):371-80. PubMed ID: 22287061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual substrate-controlled kinase activity leads to polyphosphorylated lasso peptides.
    Zhu S; Fage CD; Hegemann JD; Yan D; Marahiel MA
    FEBS Lett; 2016 Oct; 590(19):3323-3334. PubMed ID: 27585551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel gratisin derivatives with high antimicrobial activity and low hemolytic activity.
    Tamaki M; Imazeki Y; Shirane A; Fujinuma K; Shindo M; Kimura M; Uchida Y
    Bioorg Med Chem Lett; 2011 Jan; 21(1):440-3. PubMed ID: 21095123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lasso peptides: an intriguing class of bacterial natural products.
    Hegemann JD; Zimmermann M; Xie X; Marahiel MA
    Acc Chem Res; 2015 Jul; 48(7):1909-19. PubMed ID: 26079760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S.
    Lee DL; Hodges RS
    Biopolymers; 2003; 71(1):28-48. PubMed ID: 12712499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure, activity and interactions of the cysteine deleted analog of tachyplesin-1 with lipopolysaccharide micelle: Mechanistic insights into outer-membrane permeabilization and endotoxin neutralization.
    Saravanan R; Mohanram H; Joshi M; Domadia PN; Torres J; Ruedl C; Bhattacharjya S
    Biochim Biophys Acta; 2012 Jul; 1818(7):1613-24. PubMed ID: 22464970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectivity Modulation and Structure of α/aza-β
    Laurencin M; Simon M; Fleury Y; Baudy-Floc'h M; Bondon A; Legrand B
    Chemistry; 2018 Apr; 24(23):6191-6201. PubMed ID: 29411917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influences of disulfide connectivity on structure and antimicrobial activity of tachyplesin I.
    Shi J; So LY; Chen F; Liang J; Chow HY; Wong KY; Wan S; Jiang T; Yu R
    J Pept Sci; 2018 Jun; 24(6):e3087. PubMed ID: 29870123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xanthomonins I-III: a new class of lasso peptides with a seven-residue macrolactam ring.
    Hegemann JD; Zimmermann M; Zhu S; Steuber H; Harms K; Xie X; Marahiel MA
    Angew Chem Int Ed Engl; 2014 Feb; 53(8):2230-4. PubMed ID: 24446383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The astexin-1 lasso peptides: biosynthesis, stability, and structural studies.
    Zimmermann M; Hegemann JD; Xie X; Marahiel MA
    Chem Biol; 2013 Apr; 20(4):558-69. PubMed ID: 23601645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformation and antimicrobial activity of linear derivatives of tachyplesin lacking disulfide bonds.
    Rao AG
    Arch Biochem Biophys; 1999 Jan; 361(1):127-34. PubMed ID: 9882437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.